We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
HX Diagnostics, maker of quick-acting diagnostic tests for infectious diseases, brought in $4.7 million in equity and securities, according to a filing with the SEC. The company has previously been backed by Kleiner Perkins Caufield & Byers.
VentureBeat's mission is to be a digital town square for technical decision-makers to gain knowledge about transformative enterprise technology and transact. Learn more about membership.